Mark Agulnik Selected Research

Mark Agulnik Research Topics

Disease

40	Neoplasms (Cancer) 03/2024 - 05/2006
31	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 02/2008
13	Squamous Cell Carcinoma of Head and Neck 12/2021 - 03/2006
8	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 01/2008
5	Disease Progression 11/2020 - 01/2013
4	Synovial Sarcoma (Synovioma) 03/2024 - 01/2018
4	Mucositis 07/2016 - 07/2008
3	Carcinogenesis 10/2023 - 03/2006
3	Fatigue 11/2022 - 11/2015
3	Hemangiosarcoma (Angiosarcoma) 10/2022 - 01/2021
3	Thyroid Neoplasms (Thyroid Cancer) 06/2018 - 09/2015
3	Neutropenia 01/2017 - 01/2010
3	Febrile Neutropenia 01/2017 - 07/2016
2	Myxoid Liposarcoma 03/2024 - 01/2022
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 01/2018
2	Chondrosarcoma 01/2023 - 01/2022
2	Injection Site Reaction 11/2022 - 01/2016
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2019
2	Nasopharyngeal Carcinoma 10/2018 - 08/2007
2	Nausea 07/2016 - 01/2016
2	Vomiting 07/2016 - 01/2016
2	Hypertension (High Blood Pressure) 11/2015 - 01/2010
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2014 - 02/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013 - 09/2008
2	Exanthema (Rash) 09/2012 - 03/2009
2	Adenoid Cystic Carcinoma (Cylindroma) 08/2009 - 09/2007
1	Rhabdoid Tumor (Rhabdoid Tumors) 12/2023
1	Adenosarcoma 12/2023
1	Hyperplasia 12/2023
1	Genetic Translocation (Chromosomal Translocation) 10/2023
1	Hypophosphatemia 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Bone Neoplasms (Bone Cancer) 01/2023
1	Neoplasm Micrometastasis 11/2022
1	Fever (Fevers) 11/2022
1	Fetal Death 01/2022
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2022
1	Diarrhea 01/2021

Drug/Important Bio-Agent (IBA)

9	Tyrosine Kinase InhibitorsIBA 06/2018 - 02/2008
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 07/2016
6	ErbB Receptors (EGF Receptor)IBA 05/2017 - 09/2007
5	pazopanib FDA Link 10/2022 - 01/2010
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 06/2007
4	AnthracyclinesIBA 03/2024 - 07/2016
4	regorafenibIBA 01/2023 - 01/2018
4	Monoclonal AntibodiesIBA 05/2017 - 08/2008
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2017
3	NivolumabIBA 01/2021 - 05/2017
3	olaratumabIBA 01/2020 - 07/2016
3	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 09/2010
3	lenvatinibIBA 06/2018 - 09/2015
3	Sorafenib (BAY 43-9006)FDA Link 01/2016 - 08/2007
3	Lapatinib (GW572016)FDA Link 01/2014 - 09/2007
3	Antineoplastic Agents (Antineoplastics)IBA 02/2013 - 10/2006
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2024 - 01/2023
2	Ifosfamide FDA LinkGeneric 03/2024 - 01/2022
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2023 - 02/2008
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2022
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2022 - 01/2010
2	atezolizumabIBA 01/2022 - 01/2021
2	B7-H1 AntigenIBA 01/2022 - 10/2018
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
2	Alanine Transaminase (SGPT)IBA 01/2021 - 11/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 11/2015
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2017 - 08/2008
2	Cetuximab (Erbitux)FDA Link 05/2017 - 08/2008
2	isophosphamide mustard (IPAM)IBA 01/2017 - 11/2016
2	IodineIBA 01/2016 - 09/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2010 - 06/2007
2	Investigational DrugsIBA 06/2008 - 02/2008
1	HLA-A Antigens (HLA-A)IBA 03/2024
1	Keratins (Keratin)IBA 12/2023
1	SynaptophysinIBA 12/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2023
1	Proto-Oncogene Proteins c-etsIBA 10/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	AntigensIBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	VaccinesIBA 11/2022
1	GangliosidesIBA 11/2022
1	AntibodiesIBA 11/2022
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 11/2022
1	CateninsIBA 01/2022
1	Alkylating AgentsIBA 01/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2021
1	IpilimumabIBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021

Therapy/Procedure

42	Therapeutics 04/2024 - 03/2006
29	Drug Therapy (Chemotherapy) 03/2024 - 05/2006
7	Immunotherapy 03/2023 - 05/2017
6	Radiotherapy 01/2023 - 12/2006
3	Aftercare (After-Treatment) 08/2014 - 08/2007
3	Molecular Targeted Therapy 03/2013 - 01/2008
2	Neoadjuvant Therapy 11/2015 - 04/2014
2	Chemoradiotherapy 10/2013 - 09/2008
1	Drug Tapering 01/2023
1	Metastasectomy 11/2022
1	Hemipelvectomy 01/2022
1	Self-Help Devices (Assistive Technology) 01/2022